ID: ALA4797743

Max Phase: Preclinical

Molecular Formula: C27H33N7O2S

Molecular Weight: 519.68

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CN(C)CCCN1CCc2c(sc3ncnc(Nc4ccc(N(C)C)c(NC(=O)c5ccco5)c4)c23)C1

Standard InChI:  InChI=1S/C27H33N7O2S/c1-32(2)11-6-12-34-13-10-19-23(16-34)37-27-24(19)25(28-17-29-27)30-18-8-9-21(33(3)4)20(15-18)31-26(35)22-7-5-14-36-22/h5,7-9,14-15,17H,6,10-13,16H2,1-4H3,(H,31,35)(H,28,29,30)

Standard InChI Key:  RBAUOYBHKSQNCH-UHFFFAOYSA-N

Associated Targets(Human)

Serine/threonine-protein kinase TNNI3K 615 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Epidermal growth factor receptor erbB1 33727 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Receptor protein-tyrosine kinase erbB-2 7851 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Vascular endothelial growth factor receptor 1 6262 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Vascular endothelial growth factor receptor 2 20924 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

H9c2 3506 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serine/threonine-protein kinase TNNI3K 2 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mitogen-activated protein kinase 1 and 3 (ERK2 and ERK1) 27 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 519.68Molecular Weight (Monoisotopic): 519.2416AlogP: 4.66#Rotatable Bonds: 9
Polar Surface Area: 89.77Molecular Species: BASEHBA: 9HBD: 2
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.40CX LogP: 3.78CX LogD: 1.79
Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.33Np Likeness Score: -2.21

References

1. Pang H,Wang N,Chai J,Wang X,Zhang Y,Bi Z,Wu W,He G.  (2020)  Discovery of novel TNNI3K inhibitor suppresses pyroptosis and apoptosis in murine myocardial infarction injury.,  197  [PMID:32344181] [10.1016/j.ejmech.2020.112314]

Source